Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome".

Thumbnail Image

Files

JL_Response to Letter by Hansen et al - Pembro Diabetes - FINAL.pdf (331.45 KB)

Embargo End Date

ICR Authors

Spain, Lavinia
 Larkin, James

Authors

Spain, L
Larkin, J
Martin-Liberal, J

Document Type

Journal Article

Date

2016-06-01

Date Accepted

2016-05-07

Abstract

Citation

Cancer immunology, immunotherapy : CII, 2016, 65 (6), pp. 769 - 770

DOI

10.1007/s00262-016-1845-2

URI

https://repository.icr.ac.uk/handle/internal/589

Rights

https://www.rioxx.net/licenses/all-rights-reserved

Source Title

Publisher

SPRINGER

ISSN

0340-7004

eISSN

1432-0851

Collections

Clinical Studies

Research Team

Melanoma and Kidney Cancer

Notes